ECOG performance status of less than or equal to (</=) 1
ECOG performance status 0 or 1
ECOG performance status =< 2
ECOG performance status 0 or 1
Performance status 0, 1 or 2
ECOG performance status 0-2
Patients must have an ECOG performance status of 0-2
CRITERIA FOR MAINTENANCE THERAPY-STEP 4: Patients must have an ECOG performance status of 0-3
ECOG performance status 0-2
ECOG performance status 0-1.
ECOG performance status ? 1
ECOG performance status <1
ECOG Performance Status ? 1.
ECOG performance status of 0-1.
WHO performance status of 0 or 1
Performance Status of 0, 1, or 2
ECOG < 2
ECOG performance status of 0 or 1
5. ECOG performance status of 0 or 1;
ECOG Performance Status of 0-1
ECOG Performance Status of 0 or 1
Have a performance status of ? 1 on the ECOG Performance Scale
ECOG performance status 0 or 1
ECOG performance-status score of 2 or less
Performance status of 0 or 1
ECOG performance status score ? 2.
ECOG ? 2
ECOG performance status of 0 or 1
ECOG performance status 0 to 2
ECOG Performance Status of 0 or 1
The ECOG performance status must be 0 or 1.
ECOG performance status less than or equal to 3
ECOG Performance Status 0-2
ECOG Performance Status ? 2
ECOG Performance status of 0 or 1
COHORT 2: ECOG performance status < 2
Must have an ECOG performance status of 0 - 2, or KPS ? 60.
Performance status of 0 or 1
Performance status 0-1.
ECOG performance status of 0 or 1
ECOG performance status of 0-2
ECOG performance status Grade 0-2
ECOG Performance Status ? 1
ECOG ? 1
ECOG performance status of 0,1 or 2
Performance status of Eastern Cooperative Oncology Group (ECOG) 0-2; patients with ECOG of 3 may be allowed to enroll after discussion with the regulatory-sponsor/principal investigator and medical monitor, and if the performance status is believed to be secondary to lymphoma related symptoms and performance status is expected to improve once chemotherapy commences
ENDOCRINE RESISTANT AND ADJUVANT COHORT: ECOG performance status of 0, 1 or 2
Patient with ECOG ? 2
ECOG performance status of 0 - 2 and estimated survival of at least 3 months
ECOG performance status 0-1 (appendix I) documented within 90 days prior to randomization.
ECOG 0-2
ECOG performance status ?2.
ECOG performance status of 0, 1, or 2.
ECOG 0 or 1
ECOG performance status of 0 or 1
ECOG performance status 0 or 1.
ECOG performance status 0 or 1
ECOG performance status of 0 or 1 at enrollment
The ECOG performance status must be 0-1.
ECOG performance status of 0, 1, or 2
ECOG performance status 0-1
Patient with an ECOG performance status 0 or 1
Adequate Performance Status
Has an ECOG Performance Status of 0 or 1.
Must have Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1, assessed within 14 days prior to randomization. Two observers qualified to perform assessment of the performance status will be required to perform this assessment. If discrepant, the one with the most deteriorated performance status will be considered true.
Performance status =< 2
ECOG 0 or 1
ECOG performance status ? 1.
ECOG performance status of 0 or 1.
ECOG >2 performance status (Appendix A)
ARM 2 - A: ECOG performance status =< 3
ECOG performance status 0-1
ECOG 0-2
ECOG Performance Status of ? 2
ECOG performance status 0-2.
Patient has a WHO performance status 0-1
ECOG Performance status of ? 2
Subjects must have an ECOG performance status of 0-2
Adequate performance status: ECOG ? 2;
Performance Status: ECOG 0, 1, and 2 (See Appendix III)
ECOG Performance status 0-1 within 8 weeks prior to study registration.
ECOG performance status less than or equal to 3
ECOG performance status of </= 2
ECOG performance status of 2 or greater
ECOG Performance status of 0 or 1.
Patients must have an ECOG performance status of 0-1
ECOG performance status 0-1 (appendix II) assessed within 90 days of randomization.
ECOG performance status score of 2 or less
ECOG performance status of 0 or 1
Performance status of 0-3
ECOG performance status ? 2. (Patients with lower performance status based solely on bone pain secondary to multiple myeloma may be eligible following consultation and approval of the medical monitor)
Must have ECOG performance status of 0 or 1
Performance status of 0, 1, or 2
ECOG performance status (0-2)
COHORT 2: TRIPLE NEGATIVE BREAST CANCER: ECOG performance status 0 or 1
COHORT 3: ENDOMETRIAL CANCER: ECOG performance status 0 or 1
ECOG performance status of 2
Good performance status
ECOG performance status 0 or 1
Participant must have an ECOG Performance status:
Have performance status of 0 or 1 on the GOG performance scale
ECOG performance status 0-1
Participants must have an ECOG performance status of less than or equal to 1
Have a performance status of 0 or 1 on the ECOG performance scale.
ECOG status <3
Have adequate performance status (ECOG 0-2)
ECOG 3 - 4
ECOG 0 or 1
ECOG performance status ?2
ECOG performance status 0-1
ECOG performance status of 0, 1 or 2
ECOG 0 or 1
ECOG performance status of 0, 1 or 2
ECOG performance status > 1
ECOG performance status of 0 or 1 (51), or KPS of 100% to 80% (52)
PHASE II: ECOG performance status =< 2
Performance status of 0 to 3
Performance Status (ECOG) 0-1 at study entry;
ECOG of 0 or 1
An ECOG Performance Status of 0 to 1 and Karnofsky Performance Status of 80 - 100
Participant must have an ECOG Performance status:
ECOG status <3
Have adequate performance status (ECOG 0-2)
Performance status =< 3
ECOG 0-2
ECOG performance status of 0 or 1
Performance status =< 1
ECOG performance status > 2
Performance status of 0 or 1
ECOG performance status 0 or 1.
Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) status of 0-1; ECOG performance status 2 and 3 will be allowed only if decline in performance status is thought to be directly secondary to breast cancer disease burden by treating physician
ECOG performance status of 2
Performance status of 0-3
PHASE II: Patients must have an ECOG performance status of 0-1
ECOG performance status ? 2
ECOG performance status of 0-2 (dose escalation phase); ECOG performance status of 0-1 (expansion phase).
Performance status of 0, 1, or 2
PHASE II SCLC: ECOG performance status =< 2
mCRPC EXPANSION COHORT: ECOG performance status =< 2
ECOG Performance Status of 0 or 1.
ECOG performance status of 0-2 (inclusive)
ECOG performance status ? 1
Have a performance status of 0 or 1 on the ECOG Performance Scale.
ECOG performance status of < 1 on Day1 Cycle 1
ECOG performance status of 0 or 1.
ECOG performance status 0-1
ECOG performance scale of 0-1
ECOG Performance Status of 0-1.
WHO Performance Status 0, 1 or 2. A maximum of 1/3 of patients in cohorts A & B may be WHO performance status 2
ECOG >2 performance status (Appendix D)
ECOG performance status between 0 and 2
Must have adequate performance status:
ECOG Performance Status of 0 or 1
Clinical performance status of ECOG 0-1 within 30 days of signing informed consent
ECOG performance status of 0 or 1
ECOG performance status of ? 2.
ECOG performance status ? 1
Performance status of 0, 1, or 2
ECOG performance status of 3
Performance status ECOG 0-2
ECOG status 3 or 4
ECOG performance status of 0-2.
ECOG performance status ? 2
ECOG performance status > 1
The patient must have an ECOG performance status of 0, 1.
The ECOG performance status must be greater than or equal to 2.
Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 (performance status of 2 will be allowed if poor performance status is thought to be directly secondary to patient’s Hodgkin lymphoma [HL])
ECOG Performance Status of 0 or 1.
Performance status =< 2
ECOG performance status 0-1
ECOG performance status 0-2
For Phase I and II: ECOG Performance Status </= 2
ECOG performance =< 2 at the time of second registration
ECOG functional status 0-2
ECOG performance status </=2.
Clinical performance status of ECOG 0-2 within 14 days of lymphodepletion (Turnstile II)
ECOG performance status 0-1.
Performance status 0-2
Have an ECOG performance status of ? 1
Performance status >= 60%
Performance status >= 2
ELIGIBILITY CRITERIA FOR REGISTRATION: ECOG performance status =< 2
ECOG performance status of 3 or 4
Performance status will not be considered
ECOG performance status of 3 and 4
ECOG performance status of ? 2 at study entry (see Appendix A).
Poor performance status (ECOG > 1)
Performance status =< 3
ECOG performance status of 0 or 1
Subject has ECOG performance status 0 to 1.
ECOG Performance Status of 0 or 1
The patient must have an ECOG performance status of 0, 1.
WHO performance status 0-1
The ECOG performance status must be 0 or 1
ECOG Performance Status III or IV;
ECOG performance status of ? 2.
ECOG ?2.
ECOG Performance Status ? 1.
ECOG performance status 0- 2
ECOG performance status of ?2.
Performance status ECOG 0-1
ECOG performance status 0-1.
Has an ECOG performance status score of 0 to 2.
ECOG performance 0, 1 or 2
ECOG performance status of 0 or 1 at screening.
Adequate performance status (ECOG 0 or 1). (Appendix 1)
Patient with ECOG ? 2
ECOG performance status 0-2.
ECOG performance status 0-2 (Appendix 3)
ECOG 0,1
ECOG performance status 0 to 2
ECOG performance status of 0, 1, or 2
ECOG performance status ?2.
ECOG performance status 0 or 1.
ECOG performance status of 0, or 1, or 2
ECOG Performance Status 0 - 1
ECOG performance status 0 or 1
ECOG performance status 0 to 1
ECOG performance status of 0/1
ECOG performance status of 0-2
ECOG performance status within 48 hours prior to induction chemotherapy ? 3
ECOG performance status ? 3
Adequate performance status (ECOG 0 or 1) (Appendix 1)
ECOG performance status 0 to 2;
ECOG 3 or 4
Have ECOG performance status of 0 or 1
Have an ECOG Performance Status score of 0 to 2.
ECOG performance status 0-1
ECOG performance status ? 2
Performance status (ECOG) of 0-2.
ECOG performance status of 0 - 1 (Appendix C).
ECOG ? 1
Patients must have an ECOG performance status of 0-2
Patients must have an ECOG performance status of 0 -2
DOSE EXPANSION COHORT: ECOG performance status 0-2
Step 2: ECOG performance status =< 1
ECOG performance status 0-2
ECOG performance status of 0 to 1
Performance status 0-1
Performance status of 0 or 1
PHASE II: Patients must have ECOG performance status of 0 or 1
Patients must have ECOG performance status of < 2.
Patients must have an ECOG performance status of 0, 1 or 2
Clinical performance status equivalent to ECOG 0-1 at the clinical visit prior to apheresis
PHASE II: ECOG performance status 0 or 1
ECOG performance status =< 2
ECOG performance status of 2, 3, or 4
ECOG performance status of 0 or 1
ECOG performance status of 0 or 1.
Performance Status:
Cohort A (asymptomatic): ECOG performance status ?1 Cohort B (symptomatic): ECOG performance status ?2
Acceptable ECOG status 0, 1, or 2;
ECOG performance status 0, 1 or 2
ECOG performance status of ? 1.
Performance status 0-1
ECOG Performance Status 0 or 1
ECOG Performance status of 0 to 2.
Eastern Cooperative Oncology Group (ECOG) performance status of 0-2; patients with ECOG performance status of 3 will be eligible if the lower performance status is deemed by the investigator to be due entirely to accelerated or blastic phase MPN and not due to another comorbidity
ECOG performance status of 0 or 1.
ECOG performance status of 0 to 2.
ECOG performance status of 0, 1, or 2.
ECOG performance status of 0-1 (score of 2 may be acceptable)
ECOG performance status of 0-1
ECOG performance status of 0-1
ECOG performance status of 0-1 (score of 2 may be acceptable)
ECOG performance status of 0 to 1
ECOG performance status of 0 or 1
ECOG performance status 0-2.
ECOG performance status ? 1
ECOG Performance Status <= 1.
Kamofsky performance status ?70%
ECOG performance status ? 2.
Has an ECOG performance status of 0 or 1.
ECOG performance status 0-2
Patients with GOG performance status of 2, 3 or 4; or ECOG performance status of 2, 3 or 4
ECOG performance status of ? 2.
ECOG performance status ?2
Lansky performance status ? 50% (children) or Karnofsky performance status ? 70% (adults) or ECOG performance status 0-2 (adults)
ECOG performance status 0 to 1
ECOG status ?1.
ECOG performance status of ? 2
ECOG performance status ? 2
ECOG of 0 to 1
ECOG performance status <2
Patients must have an ECOG Performance Status ? 1.
ECOG performance status 0 or 1
Patients must have a ECOG performance status of 0 or 1
ECOG Performance status of 0 to 1.
Patient has an ECOG performance status ? 2 (Patients with lower performance status based solely on bone pain secondary to multiple myeloma will be eligible)
ECOG Performance Status 0-1.
ECOG performance status ? 1
ECOG Performance Status score of ? 1
ECOG Performance Status 0, 1, or 2
ECOG Performance Status of ? 2
ECOG Performance Status of ? 2.
ECOG Performance Status of ? 2
ECOG Performance Status of ? 2.
ECOG Performance Status of ? 1.
Patients with ECOG performance grade of 3 or 4
ECOG ?2.
ECOG status of 0 or 1.
ECOG Performance Status less than or equal to 2
ECOG Performance status 0 or 1
Performance Status 0-2;
ECOG Performance Status score 0 or 1
Have a performance status of 0 or 1 on the ECOG performance scale
Performance status of 0, 1 or 2 within 28 days prior to registration
ECOG performance status >2 after optimization of analgesics
ECOG performance status of 0 to 1
ECOG 0 or 1
Have an ECOG Performance Status 0 or 1 at Screening
ECOG performance status of 0 or 1
ECOG performance status ?1
Have a performance status of 0 or 1 on the ECOG Performance Scale.
ECOG performance status of 0 or 1 (see Error! Reference source not found.).
Performance Status 0-1
Performance status must be 0-1.
ECOG performance status ? 1
Has ECOG performance status 0 or 1 on Cycle 1, Day 1
ECOG performance status 0-2
ECOG performance status of 0-1
ECOG performance status </= 2
ECOG performance status 0 or 1
ECOG performance status between 0-2
Patients with any performance status are eligible for enrollment
Patients must have an ECOG performance status of 0-1
(ECOG) performance status of 0-2
ECOG ? 2
ECOG performance status ? 3;
ECOG Performance Status of 0 or 1 at Screening
WHO performance status of 3 or 4
ECOG Performance Status ? 2
ECOG performance status of 0-2.
ECOG Performance Status: 0-1
ECOG Performance Status 0 or 1.
ECOG performance status of 0 or 1.
-  Subject has an ECOG performance status ? 1 at Screening and on Day 1.
ECOG performance status of 0-2.
ECOG performance status of 0 or 1
Performance status 0 or 1
ECOG performance status of 0 or 1
Patients who have received two or three prior regimens must have an ECOG performance status of 0 or 1
ECOG performance status of 0 or 1.
ECOG 0 or 1
ECOG performance status of 0 to 1
Have a performance status of 0 or 1 on the ECOG Performance Scale within 14 days prior to registration.
ECOG performance status ? 1
ECOG performance status of 0 or 1
ECOG performance status of 0-2, Karnofsky Performance Status ?60 (for glioma subjects).
WHO/ECOG performance status of 0 or 1;
ECOG Performance Status of 2 - 3;
DONOR: ECOG performance status 0 or 1
ECOG performance status > 3
ECOG performance status =< 2, unless the decline of the performance status is considered to be related to CLL symptoms
ECOG performance status of 0-2
WHO/ECOG performance status of 0 or 1
ECOG performance status of 0 to 2.
Subject must have an ECOG performance status of 0 or 1.
Have a performance status ?1 on the ECOG scale
ECOG 0 to 2
ECOG performance status of 0 - 1.
GOG performance status 0-2;
ECOG performance status between 0-2
PHASE II: ECOG performance status =< 1
ECOG performance status of 0 - 1
ECOG performance status of ? 2.
ECOG performance status of ) to 1
ECOG performance status 0-1.
ECOG performance status >= 2
ECOG performance status of 0-2.
ECOG Performance Status of 0 or 1.
ECOG Performance Status of 0 or 1
ECOG Performance status 0-1
ECOG performance status 0 or 1.
ECOG performance status ?2
ECOG performance status of 0-2.
ECOG performance status of 0 or 1
ECOG performance status < 2
ECOG performance status of 0 or 1
ECOG performance status < 2
REGISTRATION INCLUSION CRITERIA: ECOG performance status =< 1
ECOG status of >= 2
WHO performance status 0-2
ECOG performance status ? 2
ECOG Performance Status of 0, 1 or 2.
ECOG Performance Status of 0, 1, or 2
ECOG performance status of < 3.
Eastern Cooperative Oncology Group (ECOG) performance status =< 2; patients with ECOG performance status of 3 (defined as being capable of only limited self-care, confined to bed or chair more than 50% of waking hours) will also be eligible only if the lower performance status is judged to be directly related to steroid and/or cGVHD effects
ECOG performance status of 0, 1, or 2
Performance status >= 60%
ECOG performance status of 0-1.
ECOG Performance Status 0 or 1.
ECOG performance status of 0 or 1
The patient has an ECOG performance status of 0, 1, or 2
ECOG performance status ? 1
ECOG Performance Status: 0-2
ECOG performance status 0-2 (all cohorts)
Performance status 0-1
Patients must have an ECOG performance status of =< 2
ECOG performance status of < = 2 at study entry.
WHO performance status of ? 1
ECOG Performance Status of ? 3
Pre-study ECOG performance status 0-2. Patients with lower performance status based solely on bone pain will be eligible.
Performance status of 0, 1, or 2
ECOG performance status ? 1 Patients must have normal organ and marrow function as defined below:
ECOG performance status of 0 or 1.
ECOG Performance Status of </= 2
ECOG performance status 0-1
ECOG performance status 0 to 1
Have an ECOG Performance of 0-2
ECOG performance status ? 1
An ECOG performance status of 2
ECOG performance status ? 2
ECOG Performance Status of 0 or 1
ECOG performance status 0 to 1;
ECOG performance status score of 0-2.
ECOG Performance Status < 1
ECOG of 0 or 1
Patients with an ECOG Performance Status of 0, 1, or 2.
Patients with ECOG Performance Grade of 3 or 4
ECOG Performance Status of 0, 1, or 2
ECOG performance status 0-1
ECOG performance status 0 or 1
ECOG performance status > 2
ECOG performance status of 0-3
Must have an ECOG performance status score of less than or equal to 2.
ECOG Performance Status of 0 or 1.
ECOG performance status less than or equal to 2
ECOG of 0 or 1.
Participant must have an ECOG performance status score of 0 or 1
ECOG Performance Status of 0 or 1
ECOG performance status of 0 to 1
ECOG performance status 0-1
ECOG performance status of 0 or 1, measured at screening and immediately before the start of treatment.
Adequate performance status.
Ambulatory with ECOG performance status of 0 or 1
ECOG Performance Status of 0-1
ECOG performance status of 0 or 1 (see Appendix 8)
ECOG performance status of ? 1
ECOG Performance Status 0 to 2
ECOG performance status of 0 or 1.
ECOG performance status of 0 or 1.
ECOG performance status 0-1
ECOG performance status 0 or 1
ECOG performance status of 0-1.
Adequate performance status, defined as:
Performance status:
ECOG performance status ? 2
ECOG performance status of 0 or 1
ECOG Performance Status ? 2.
Performance status of 0, 1 or 2 by the ECOG scale
ECOG status of ? 2
Performance Status of 0 or 1
ECOG performance status =< 2
ECOG Performance status 0-1 (Appendix B)
(ECOG) Performance Status of 0, 1 or 2
Performance Status of 0 or 1.
ECOG Performance Status 0-1
ECOG performance status ? 2.
ECOG performance status of 0 - 1.
ECOG Performance Status ? 1
ECOG performance status of 0-2.
WHO performance status of 0-1
ECOG performance status of 0 to 1
Patients must have an ECOG performance status of 0, 1, or 2.
TREATMENT: Patients must have an ECOG performance status of 0-2
ECOG Performance Status 0 - 1
Have a performance status of 0 or 1 on the ECOG.
ECOG Performance Status 0-2
ECOG performance status 0-2.
ECOG performance status of 0 or 1
ECOG ? 2.
Have an ECOG Performance Status of ? 1. Refer to Appendix 1.
ECOG performance status of 0 or 1
ECOG performance status of 0 to 2
ECOG performance status of 0 or 1
ECOG performance status of 0 or 1
ECOG performance status of 0 or 1
ECOG 0-1
ECOG performance status 0-2, inclusive
ECOG performance status ? 2
ECOG Performance Status score of 0, 1 or 2
ECOG performance status ? 2
ECOG Performance Status of ? 1
Performance status of 0 to 1 on the ECOG Scale
ECOG performed status of 0 or 1
ECOG Performance Status of 0 - 2.
ECOG Performance Status 0-1.
ECOG performance status 0 or 1.
Performance Status of 0 or 1
ECOG performance status of 0 or 1 (see Appendix C)
ECOG Performance Status range of 0-2
ECOG performance status score 0, 1 or 2
ECOG performance status of 0 or 1
ECOG performance status 0-2.
ECOG performance status 0 or 1
ECOG performance status of ?2
ECOG 0 or 1
ECOG performance status <3
ECOG performance status of 0 - 2. -
ECOG performance status of ?2
ECOG performance status of 0 or 1
WHO performance status of ? 2.
Low Performance Status (ECOG > 2; Appendix E).
Performance Status of 0 or 1
ECOG performance status 0-2
ECOG Performance Status 0 or 1.
ECOG performance status > 2.
ECOG performance status status >/= 2
Performance Status corresponding to ECOG score of 0, 1, or 2:
ECOG performance status ?2.
ECOG performance status of 0 - 1.
ECOG performance status ? 1
ECOG performance status of 0 to 1
ECOG Performance Status of 0 or 1
ECOG performance status of 0, 1 or 2
ECOG Performance Status less than or equal to 2
ECOG ? 2
ECOG 0, 1 or 2
ECOG performance status 0-2
ECOG performance status ?2
Patients must have ECOG performance status of 0-2
ECOG of 0 or 1
Donor must have an ECOG performance status of 0 or 1.
Recipient must have an ECOG performance status of 0 or 1.
ECOG performance status of 0, 1, or 2.
ECOG Performance Status score of 0 or 1
ECOG performance status less than or equal to 2
ECOG Performance Status ? 1.
ECOG Performance Status ? 1.
ECOG Performance Status of 0, 1, or 2.
Performance status of less than or equal to 2 on ECOG scale.
Patients must have an ECOG performance status of 0 - 1
ECOG Performance Status of 0, 1, or 2.
ECOG performance status 0-2.
ECOG Performance Status of 0, 1 or 2
ECOG performance status ? 1
ECOG performance status of either 0 or 1
ECOG Performance Status 0-2;
ECOG Performance Status 0-2
WHO performance status 0-1.
ECOG performance status of 0, 1, or 2
ECOG Performance Status ? 2
ECOG Performance Status 0 or 1
ECOG performance status =< 2
ECOG performance status =< 2
Performance status 0-2
Has an ECOG performance status of 0 or 1
ECOG > 2
Have an ECOG performance status of 0 to 1.
Subject has an ECOG Performance Status 0-1.
Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale; an ECOG performance status of 2 is acceptable if the patient was ECOG 0/1 prior to curative intent therapy and is in the midst of recovery from curative intent therapy
ECOG Performance Status ? 2.
ECOG performance status > 2
ECOG performance status < 3
Acceptable level of performance status (both)
Performance status of 2 or better
Have ECOG performance status 0-1
Patients with an ECOG performance status of 0, 1, or 2, and estimated survival of > 12 weeks.
Performance status of 0 - 1
ECOG performance status of 0 or 1
ECOG performance status 3 or worse
Patients must have a performance status of 0-2
CONTROL (HEALTHY) GROUP: ECOG performance status 0-1
ECOG performance status =< 2
Patients must have an ECOG Performance Status of < 2
ECOG performance status of 0 or 1
ECOG performance status ?2.
Performance status =< 1
ECOG performance status > 3
ECOG Performance status ? 2
Patients must have a good performance status (ECOG<2)
GOG performance status > 2
ECOG performance status of 0 or 1
ECOG performance status ?2
ECOG performance status of 0 to 2
ECOG performance status of 0, 1 or 2 at the time of enrollment.
ECOG status > 3
ECOG performance status > 3
ECOG performance status 0 or 1
ECOG performance status of ? 1
General performance status evaluated by ECOG 0-2 scale.
Performance status 0 or 1
Subject has an ECOG performance status 0 to 2.
Has an ECOG performance status of Grade 0 to 2
ECOG performance status of 0 to 2 (Appendix C)
ECOG performance status of 0 or 1
NORMAL VOLUNTEERS: Have a ECOG performance status of 0-2
The patient has ECOG performance status > 1
ECOG performance status of 0-2 (or a Karnofsky performance status of >50%)
performance status of 0 or 1
ECOG performance status of 0 to 1.
ECOG performance status of 0 or 1.
ECOG 0, 1, or 2
ECOG performance status of 0 or 1
ECOG performance status of 0-2
Eastern ECOG performance status of 0 to 2.
Subjects with ECOG performance status of 0 or 1.
ECOG performance status of 0-2.
Subjects with ECOG performance status of 0 or 1.
ECOG performance status 0-2
ECOG performance status >1.
ECOG performance status must be 0 or 1
Performance status as per protocol
ECOG performance status 0-2
ECOG performance status ? 1
ECOG performance status greater than or equal to 2